Integrated Inflammatory and Gut Microbial Signatures in Major Depressive Disorder: A Case-Control Study

Area of Science:

• Neuroscience
• Microbiology
• Psychiatry

Background:

• Major depressive disorder (MDD) involves inflammation and the microbiota-gut-brain axis.
• Limited data exists on neuroimmune-microbiome interactions in depression, especially in Middle Eastern and North African (MENA) populations.
• Diet's role in these interactions remains under-explored in depression.

Purpose of the Study:

• To investigate associations between MDD, systemic inflammatory markers, and gut microbiota composition in Lebanese adults.
• To address the scarcity of research on these interactions within the MENA region.
• To explore potential diet-influenced neuroimmune-microbiome links in depression.

Main Methods:

• Cross-sectional case-control study involving 46 adults with MDD and 25 healthy controls.
• Measured plasma C-reactive protein (CRP) and interleukin-6 (IL-6).
• Characterized gut microbiota using 16S rRNA gene sequencing, adjusting for BMI, diet, and medication.

Main Results:

• MDD was not independently associated with CRP or IL-6; BMI was a key inflammation determinant.
• MDD showed enrichment of specific genera (e.g., Dorea, Collinsella) and depletion of others (e.g., Christensenella).
• No difference in alpha diversity; beta diversity showed modest differences.

Conclusions:

• Specific gut microbial taxa may influence gut-brain signaling in MDD.
• These findings suggest potential microbial targets for understanding MDD and systemic inflammation.
• Further longitudinal and mechanistic studies are needed to confirm causality.